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Abstract
Background: Adipose-derived stem cells (ASCs) are being increasingly recognized for their potential to promote
tissue regeneration and wound healing. These effects appear to be partly mediated by paracrine signaling
pathways, and are enhanced during hypoxia. Mass spectrometry (MS) is a valuable tool for proteomic profiling of
cultured ASCs, which may help to reveal the identity of the factors secreted by the cells under different conditions.
However, serum starvation which is essentially required to obtain samples compatible with secretome analysis by
MS can have a significant influence on ASCs. Here, we present a novel and optimized culturing approach based on
the use of a clinically relevant serum-free formulation, which was used to assess the effects of hypoxia on the ASC
proteomic profile.
Methods: Human ASCs from three human donors were expanded in StemPro® MSC SFM XenoFree medium.
Cells were cultured for 24 h in serum- and albumin-free supplements in either normoxic (20 %) or hypoxic (1 %)
atmospheres, after which the cells and conditioned medium were collected, subfractionated, and analyzed using
MS. Prior to analysis, the secreted proteins were further subdivided into a secretome (>30 kDa) and a peptidome
(3–30 kDa) fraction.
Results: MS analysis revealed the presence of 342, 98, and 3228 proteins in the normoxic ASC secretome, peptidome,
and proteome, respectively. A relatively small fraction of the proteome (9.6 %) was significantly affected by hypoxia,
and the most regulated proteins were those involved in extracellular matrix (ECM) synthesis and cell metabolism. No
proteins were found to be significantly modulated by hypoxic treatment across all cultures for the secretome and
peptidome samples.
Conclusions: This study highlights ECM remodeling as a significant mechanism contributing to the ASC regenerative
effect after hypoxic preconditioning, and further underscores considerable inter-individual differences in ASC response
to hypoxia. The novel culture paradigm provides a basis for future proteomic studies under conditions that do not
induce a stress response, so that the best responders can be accurately identified for prospective therapeutic use.
Data are available via ProteomeXchange with identifier PXD003550.
Keywords: ASCs, Proteomics, Hypoxia, Serum-free culture, Secretome, ECM, Mass spectrometry
* Correspondence: trinef@hst.aau.dk
1Department of Health Science and Technology, Laboratory for Stem Cell
Research, Aalborg University, Fredrik Bajers Vej 3B, Aalborg 9220, Denmark
Full list of author information is available at the end of the article
© 2016 Riis et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Riis et al. Stem Cell Research & Therapy  (2016) 7:52 
DOI 10.1186/s13287-016-0310-7
Background
Human adipose-derived stem cells (ASCs) have come
under scrutiny for their putative use in regenerative medi-
cine based on their immunomodulatory, pro-angiogenic,
pro-trophic, and anti-apoptotic properties [1–4]. ASCs are
of particular interest for the treatment of chronic wounds
as they may restart the healing process by reducing inflam-
mation, supporting ingrowth of new vessels into the hyp-
oxic tissue, and promoting fibroblast and keratinocyte
proliferation and migration [5]. While the molecular mech-
anisms are not fully explained, it is apparent that some of
these regenerative properties of ASCs are associated with
secreted factors in the form of growth factors, cytokines,
and extracellular vesicles [6–9]. In addition to the impact
on the inflammatory and proliferative phases of wound
healing, it also appears that ASCs have a positive effect on
the formation and remodeling of the extracellular matrix
(ECM) [10]. This is particularly important as the ECM is
degraded or otherwise compromised during the chronic
wound process [11].
It has been demonstrated that the regenerative potential
of ASCs and other mesenchymal stem cells is enhanced by
hypoxic conditioning prior to use [12, 13]. Of interest to
wound healing, hypoxic treatment induces an increase in
ASC secretion of factors relevant to the inflammation and
proliferation phases, such as interleukin (IL)-10, basic fibro-
blast growth factor (bFGF), vascular endothelial growth
factor (VEGF), stromal cell-derived factor 1 (SDF-1),
insulin-like growth factor-1 (IGF-1), caspase 9 (CASP9),
and bcl-2 associated X protein (BAX) [2, 14–18]; 1 % O2
has especially been shown to increase the secretion of para-
crine factors [16]. The identified factors, however, represent
only a subset of the entire secretome, and it is probable that
as yet unidentified factors play an important role in the
wound healing mediated by hypoxia-preconditioned ASCs.
To perform a more global characterization of the effect
of hypoxia on ASCs, transcriptional profiling using micro-
arrays has been used to assess the effect on the transcrip-
tion of a large number of pre-selected genes [19]. High-
throughput RNA sequencing that allows for detection of
unknown transcripts, and that has been shown suitable
for discrimination between distinct ASC subpopulations
and between cell populations within the stem cell niche
[20, 21], would be another option; however, we have
not identified any such study. Both microarrays and
RNA sequencing have developed into cost-effective and
robust techniques. A serious drawback, however, is the
concern regarding a lack of correlation between regula-
tion of transcripts and proteins, particularly when it
comes to upregulated genes following perturbation of
steady-state conditions [22, 23]. As it is increasingly
clear that mRNA abundance does not necessarily reflect
the corresponding protein abundance, post-translational
modifications, or subcellular location, much effort has
been dedicated to characterize and quantitate the ASC
secretome in particular [24], and also to some extent the
proteome [25]. Techniques used to characterize the effect
of hypoxia on the ASC protein profile range from
enzyme-linked immunosorbent assay (ELISA), Western
blotting, and antibody-based arrays (allowing for the sim-
ultaneous analysis of relatively few pre-selected proteins),
to mass spectrometry (MS)-based methods where a much
larger gamut of proteins can be identified and quantitated
(see [24], and references therein). Generally, the large-
scale study of proteins in cells or tissue can be made by
two proteomics strategies, either using one- or two-
dimentional gel electrophoresis or non-gel-based tech-
niques. In non-gel-based techniques, sample proteins are
enzymatically digested in solution phase and separated
using liquid chromatography in line with a tandem MS
(LC-MS/MS) system [26]. During MS and tandem MS
analysis the exact mass and amino acid sequence informa-
tion for each peptide are obtained. The proteins in the
sample can then be identified using database search algo-
rithms and quantified by comparing the peptides to data-
bases containing protein information based on translated
genome and mRNA sequences [27].
In previous studies, where the proteome and secre-
tome of ASCs have been analyzed by MS, cells have
been expanded in medium supplemented with fetal calf
serum (FCS), followed by extensive washes and culture
in serum-free conditions for 24–72 h prior to collection
of conditioned media/cell lysis [28–30]. This period of
serum starvation has been necessary as the presence of
high levels of serum proteins, e.g., albumin, found in
serum would mask the presence of low-abundant pro-
teins [31]. However, the process of serum starvation in
itself frequently leads to unwanted cell responses, in-
cluding membrane blebbing and growth arrest [32–34],
and has been shown to induce a robust response in
ASCs, altering the transcription of more than 100 genes
[35]. Several serum-free medium formulations that sup-
port the clinically compliant expansion of ASCs are
commercially available [36]. In particular, studies have
shown that ASCs cultured using StemPro® MSC SFM
XenoFree (Thermo Fisher) maintain the essential stem
cell properties such as immunophenotype and multiline-
age differentiation potential [37, 38]. However, the ap-
plicability of serum-free medium formulations for the
culture of cells used for MS protein analysis of ASCs has
not previously been reported.
In this paper, we describe a culture protocol that allows
the growth of ASCs under clinically relevant conditions
for the production of conditioned media compatible with
MS. Growth and viability of ASCs have been assessed in
media without FCS and excessive bovine protein contam-
ination. Using the optimal medium formulation for cul-
ture and preconditioning of the ASCs we used MS-based
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proteome analysis to compare the secretome and prote-
ome of cells from three different donors cultured under




ASCs from three donors were isolated as previously de-
scribed after written informed consent from the donors
and approval by the regional committee on biomedical
research ethics of Northern Jutland, Denmark (project
no. VN 2005/54) [39–41]. The three different cultures
(ASC12, ASC21, and ASC23) have previously been thor-
oughly characterized by our laboratory both under nor-
moxic and hypoxic conditions, and possess
characteristics commensurate with the definition of mes-
enchymal stem cells [38, 42–47].
Media
Three different media were used: StemPro–, composed
of StemPro® MSC SFM XenoFree (Gibco™, Thermo
Fisher, www.thermofisher.com) supplemented with
2 mML-glutamine (Gibco™), and 100 U/mL penicillin
and 0.1 mg/mL streptomycin (Gibco™); StemPro+,
(StemPro– supplemented with StemPro supplement);
and StemPro E8 (StemPro– supplemented with Essential
8™ Medium supplement (Gibco™)).
Cell culture
The cells were cultured in polystyrene tissue flasks
(CELLSTAR®, Greiner Bio-One, www.gbo.com) coated
with CellStart™ CTS™ (Gibco™), in a standard incubator
in an atmosphere of 37 °C, 20 % O2 and 5 % CO2. When
replating, TrypLE Select (Gibco™) was used for cell de-
tachment. Unless stated otherwise, ASCs were cultured
in StemPro+. For all experiments the ASCs were in pas-
sage 6–8.
Expansion of ASCs in different media and cell counting
To assess the effect of different media on ASC growth,
the cells were seeded at a density of 1500 cells/cm2 in
48-well plates (CELLSTAR®) in StemPro+, StemPro–,
and StemPro E8, and cultured for up to 72 h. At 24, 48,
and 72 h the cell number was determined by measuring
the amount of DNA using a Quant-iT™ PicoGreen®
dsDNA Assay Kit (Invitrogen™). The fluorescence was
measured using a Wallac 1420 Victor Multilabel Coun-
ter with excitation and emission at 485 nm and 535, re-
spectively; 6.6 pg DNA/cell was used to calculate the cell
number. The media were tested in duplicate on each of
the three ASC cultures.
Short-term effect of different media on ASCs
ASCs were seeded in 96-well culture plates at a density
8000 cells/cm2. When the culture was 70 % confluent,
cells were washed repeatedly with phosphate-buffered
saline (PBS). The cells were then incubated for 24 h with
either StemPro+, StemPro–, or StemPro E8 media, after
which cell morphology and viability were assessed.
For the assessment of cell morphology, phase contrast
images were acquired using an Olympus CKX41 micro-
scope (Olympus Life Science) with a PixeLINK PL-A782
camera.
The proportion of viable cells was determined essen-
tially as previously described [48]. In brief, ASCs were
stained with 1 μM Yo-PRO-1 (Molecular Probes™),
10 μg/mL PI (Molecular Probes™), and 5 μg/mL Hoechst
33342 (Molecular Probes™), after which images were ac-
quired using an AxioVision software package with a
Zeiss Axio Observer.Z1 microscope equipped with an
AxioCam MRm camera (Carl Zeiss, Germany). Live,
necrotic, and apoptotic cells were counted using Image J
1.47v (NIH, USA), and the proportion of viable cells was
calculated as the fraction of Yo-PRO-1 and PI-positive
cells relative to the total cell number subtracted from 1.
The effect of the media was tested in duplicate on each
of the three ASC cultures.
Statistical analysis of cell growth and viability data
The statistical analysis was performed using SigmaPlot
12.0 (Systat Software, Erkrath, Germany). The normal
distribution of each group was assessed by means of the
Shapiro-Wilk test. Additionally, variance was tested
using an Equal Variance Test. Data are represented as
mean ± standard error of the mean (SEM). A p value of
<0.05 was considered statistically significant. For com-
parison of more than two groups, a one-way analysis of
variance (ANOVA) with Bonferroni’s post hoc test was
used.
Production and fractionation of conditioned media and
cell lysate
For an overview of the steps involved in the production
of media and cell lysate for MS, please refer to Fig. 1.
For production of conditioned media, ASCs were seeded
in T75 tissue culture flasks at a density of 8000 cells/
cm2, and incubated until approximately 70 % confluence
(72 h). The cells were washed thoroughly with PBS to
remove any albumin residues and 15 mL fresh StemPro
E8 medium was added. Half of the flasks were cultured
at 20 % oxygen, the other half at 1 % oxygen. After 24 h,
the conditioned medium (CM) was collected, centri-
fuged, and decanted before protease inhibitors were
added (1 tablet per 15 mL medium; Roche Complete
Protease inhibitor cocktail, Mini). The resulting CM was
first fractionated using spin filters into a high-molecular
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weight secretome fraction (>30 kDa) using a 30-kDa
spinfilter (Millipore, Billerica, MA, USA), and, based on
the flow-through, a low-molecular weight peptidome
fraction (3–30 kDa), where molecules smaller than
3 kDa were removed using a 3-kDa spinfilter (Millipore).
After both filtration steps, the retained proteins trapped
on the spin filters were washed twice with 4 mL TEAB
buffer (50 mM triethylamonium bicarbonate, pH 8.5),
and retained in 500 μL TEAB buffer. The protein con-
tent was measured spectrophotometrically by protein
OD A280 (Nanodrop; Thermo Science, Wilmington,
DE), and the samples were stored at –80 °C for further
analysis. All experiments were performed for all three
cell lines in two separate experiments, each in duplicate.
After harvesting the CM, the ASCs were washed twice
in PBS and the cells collected for proteome analysis
using a protease and phosphatase inhibited RIPA buffer
and subsequently sonicated to ensure complete lysis.




From each sample, a volume corresponding to 25 μg
protein was transferred to an Eppendorf tube, and
50 mM TEAB buffer, pH 8.5, was added to a total vol-
ume of 100 μL. The proteins were reduced by the
addition of 2 μl 0.5 M tris(2-carboxyethyl)phosphine
(Thermo Scientific, Waltham, MA, USA) and incuba-
tion for 30 min at 37 °C. Next, the proteins were alky-
lated by the addition of 8 μl 0.5 M chloroacetamide
(Sigma-Aldrich, St. Louis, MO, USA) and incubation
for 30 min at 37 °C in the dark. Trypsin (0.5 μg) was
added to each sample, and the proteins were digested
overnight at 37 °C. The enzymatic procedure was
stopped by addition of 5 μl 100 % formic acid. Protein
digests were dried by vacuum centrifugation and
desalted on PorosR3 nanocolumns and resuspended in
30 μL of a solution containing 2 % acetonitrile and
0.1 % formic acid.
Peptidome
The lower molecular weight proteins (3–30 kDa) were
concentrated in YM-3 kDa spinfilter (Millipore, Billerica,
MA, USA) by centrifugation at 14,000 g at 4 °C. The
retained fraction (100 μL) was processed as described
for the secretome samples.
Proteome
For the proteome analysis of the cells, a total of 25 μL of
protein lysate in modified RIPA buffer was mixed with
reducing sample buffer (2× Laemmeli; Bio-Rad,
Hercules, CA) and isolated by reducing sodium dodecyl
sulfate polyacrylamide gel electrophoresis (SDS-PAGE;
(Biorad Any kD Mini-PROTEAN® TGX). The electro-
phoresis was stopped when the protein had entered
1.5 cm into the running gel according to the applied pre-
stained protein marker (SeeBlue Plus2 pre-stained stand-
ard; Invitrogen, Carlsbad, CA). The protein load on each
gel lane was comparable. The protein was visualized by
Coomassie blue (SimplyBlue SafeStain; Invitrogen) and
50 % of each band excised and in-gel digested as de-
scribed previously [49].
Mass spectrometry analysis
The protein concentrations in the samples were normal-
ized using A280 on a NanoDrop 1000 (Thermo Scientific,
Wilmington, DE, USA), and 5 μg total peptide material
was analyzed per LC-MS analysis of the low and high mo-
lecular weight proteins. A total of 20 % of each gel band
was used for each of the biological replicates.
The samples were analyzed using a UPLC-nanoESI MS/
MS setup with an UltiMate™ 3000 RSLC nanopump mod-
ule. The system was coupled online with an emitter for
nanospray ionization (New objective picotip 360-20-10) to
a QExactive Plus mass spectrometer (Thermo Scientific,
Waltham, USA). The peptide material was loaded onto a
C18 reversed phase column (Dionex Acclaim PepMap
RSLC C18, 2 μm, 100 Å, 100 μm× 2 cm) and separated
using a C18 reversed phase column (Dionex Acclaim Pep-
Map RSLC C18, 2 μm, 75 Å, 75 μm× 50 cm) at 40 °C.
Fig. 1 Preparation of samples for mass spectrometric analysis. Following the expansion of ASCs from three donors for 72 h, cells were cultured
under either normoxic or hypoxic conditions for 24 h. The conditioned media were harvested and sequentially fractionated through 30-kDa and
3-kDa spin filters to retain the secretome and peptidome fractions, respectively. The cellular fraction was employed for the analysis of the proteome.
ASC adipose-derived stem cell
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The sample was eluted with a gradient of 96 % solvent A
(0.1 % FA) and 4 % solvent B (0.1 % FA in ACN), which
was increased to 8 % solvent B on a 5-min ramp gradient
and subsequently to 30 % solvent B on a 70-min ramp
gradient for the proteome samples and 30 min for the
secretome samples, at a constant flow rate of 300 nL/min.
The mass spectrometer was operated in positive mode,
selecting up to 12 precursor ions based on the highest in-
tensity for HCD fragmenting.
Data analysis
The reproducibility and variation of the amounts of pep-
tide per sample were determined using Progenesis QJ
for Proteomics (NonLinear/Waters, UK). A label-free
quantitation by normalized XIC was performed of the
trypsin-digested samples by searching the data files using
MaxQuant 1.5.2.8 against the Homo sapiens Uniprot ref-
erence proteome database (UPID5640; April 2015). All
standard settings were employed with carbamidomethyl
(C) as a static modification and oxidation (M) as a vari-
able modification. All proteins are reported at <1 % false
discovery rate (FDR) to ensure only high-confidence
protein identifications. The result file from MaxQuant
was analyzed in Perseus v1.5.1.6. Initially, all reverse hits
were removed from further analysis, and the data was
log2-transformed. Two unique peptides or more were
required for a protein identification and quantitation to
ensure high-quality quantitation. Scatter plots were
inspected biological-replicate wise. No replicates were
removed due to low reproducibility. To further identify
replicate outliers, a principle component analysis (PCA)
was performed using all the measured protein abun-
dances in all replicates as an input. For the purpose of
conducting PCA, missing values (i.e., proteins where a
quantitation value was not obtained for a given replicate
analysis) were replaced with values from a normal distri-
bution (width 0.3 and down shift 1.8) to simulate signals
from low abundant proteins [50].
MS measurements were grouped preservation-method
wise, and two-sided t tests were performed to identify
statistically significant changing proteins. The statistical
tests were corrected for multiple hypothesis testing
using permutation-based FDR, and the parameters were
chosen to provide sufficient input in the subsequent ana-
lysis (FDR = 0.05, s0 = 0.1, and 250 randomizations).
The genes coding for the significantly different expressed
proteins found by MS were analyzed for statistical
over-representation (enrichment) of Gene Ontology
(GO) categories in terms of biological process using
Cytoscape (version 3.3.0) with the Biological Networks
GO plug-in (BINGO, version 3.0.3) [51, 52]. An adjusted p
value of 0.05 was used as threshold for significance after
correcting for multiple testing by Benjamini and Hochberg
FDR correction. Over-representation was computed from
hypergeometric test. The dataset for each donor was com-
pared against a reference set of complete Homo sapiens
GO annotations.
Results
Optimization of culture media
StemPro + has been shown to support ASC growth [53]
but is not fully suitable for secretome analysis by MS
due to the presence of large amounts of contaminant
proteins, e.g., albumin. Low-protein and albumin-free
media formulations include StemPro– and StemPro E8,
which may offer an alternative for preconditioning of
cells for MS. Initially, to compare the performance of
the two media with StemPro+, ASCs were expanded in
the three different media for up to 72 h. Analysis of the
growth rate (Fig. 2a) revealed that StemPro + was super-
ior in supporting a stable rate of cell growth, while in
StemPro– cell growth is significantly inhibited over time.
Although the growth rate of the cells in StemProE8 was
comparable to StemPro + for the first 48 h, it decreased
significantly after 72 h. Next, to assess the effect of
short-term culture on cell number, viability, and morph-
ology, ASCs were seeded at a higher density and grown
in StemPro + for 72 h and then cultured in low-protein
and albumin-free media formulations for 24 h. In terms
of cell numbers, StemPro + and StemPro E8 were com-
parable, and StemPro– underperformed (Fig. 2b). Al-
though analysis of cell viability did not suggest that
culture in StemPro– caused compromised cell viability
(Fig. 2b), cells cultured in StemPro– displayed a slightly
more irregular morphology (Fig. 2c). Based on these re-
sults, ASCs were expanded in StemPro + and precondi-
tioned in StemPro E8 for 24 h for the production of the
CM and proteome samples for MS analysis.
Identification of proteins
For ASC12, ASC21, and ASC23 cultured in normoxia
and hypoxia, each of the quadruplicate biological repli-
cates of secretome, peptidome, and proteome was proc-
essed as described above, separated and analyzed using
UPLC-MS/MS. During this procedure, a list of the gen-
erated peptide fragments and information about the re-
tention time, the accurate precursor ion mass and its ion
intensity were obtained for each peptide. Using reverse-
phase UPLC, the peptides were separated according to
their hydrophobicity. When reaching the column, the
peptides were ionized by electron spray and the mass of
the peptide (precursor ion) was determined followed by
fragmentation by collision and mass analysis of the
resulting fragments. A good and reproducible separation
of the peptides as well as a similar sample loading
amount as determined by the total TIC was observed by
plotting the m/z against the retention time of each
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peptide using Progenesis QI for Proteomics (data not
shown).
The tandem mass spectra were used to search the Uni-
prot human reference proteome database with isoforms
(UP000005640) to uniquely identify the parent proteins.
Combining the MS1 spectra of the peptides and the
MS2 spectra of their fragments, quantification of each
protein was obtained. Validation of the UPLC-MS/MS
spectra quantification was performed by plotting the in-
tensities of proteins from each replicate against each
other (Additional file 1: Figure S1). From this, a good
correlation was found, increasing with increasing protein
intensity. This is representative for all proteome samples
with an average R = 0.98 ± 0.01.
Effect of hypoxic treatment on the ASC secretome
In total, 342 proteins were identified in the secretome of
ASC12, ASC21, or ASC23 by label-free quantitative data
analysis using MaxQuant and post-processing in Perseus
[27]. GO categories, by which at least three proteins
were annotated, are shown in Additional file 2 (Table
S1). The resulting GO profile showed that many of these
proteins had functions that were related to developmen-
tal processes including angiogenesis and vasculature de-
velopment, ECM and cell adhesion/migration, cell
survival and cell death, as well as immune regulation.
Interestingly, we did not detect any statistically signifi-
cant hypoxia-induced up- or downregulation of proteins.
Effect of hypoxic treatment on the ASC peptidome
In the peptidome fractions, only a total of 98 proteins
were identified and quantified based on strict criteria.
GO categories, by which at least three proteins were an-
notated, are shown in Additional file 3 (Table S2). The
GO profile confirmed over-representation proteins with
essentially the same functions as the proteins in the
secretome. Of the 98 identified proteins, two were found
significantly upregulated and three significantly down-
regulated in the ASC 23 cells (Additional file 4: Table
S3). However, for the other ASCs we did not observe
any significant effect of hypoxia on the MS peptidome
profile.
Effect of hypoxic treatment on the ASC proteome
For cells cultured in normoxia, 94 % of proteins (2741
out of a total of 3228) were common to both ASC 12,
ASC21, and ASC 23, with 50–100 proteins uniquely
expressed by cells from just one donor (Fig. 3a). For the
cells cultured in hypoxia, more than 85 % of proteins
were detected in all cells. Despite the high degree of
overlap between cells from different donors, the PCA re-
vealed that the variations in protein expression between
donors were larger than the variations caused by hypoxic
treatment (Fig. 3b). The technical reproducibility of the
MS setup used has previously been reported to be very
high [54]. A representative volcano plot, depicting an
analysis of the effect of hypoxia on protein expression,
illustrates that the differences in protein levels between
cells cultured in hypoxia and normoxia are less than
two-fold for most proteins (Fig. 3c), and statistically sig-
nificant for a only a relatively small fraction of proteins.
Fig. 2 Effects of culture supplements on the growth and viability of
the ASCs. a Growth curves of ASCs expanded for 3 days in the different
media formulations. At day 3, there was a significantly higher number of
cells in the StemPro + cultures as compared to the cultures with the
other two media formulations (***p < 0.001, n = 6). b Cells expanded for
3 days in StemPro + and preconditioned for 24 h in the different media.
After preconditioning, the number of cells in StemPro– cultures had
significantly decreased in relation to the StemPro + cultures (**p< 0.01,
n = 6). The percentage of viable cells was equivalent among the
different formulations. c Phase contrast microphotographs displaying
the morphology of cells after the preconditioning period in different
media. The figure shows representative pictures from one donor.
Scale bar = 200 μm
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Among the proteins regulated by hypoxic precondition-
ing, 235 (7.1 %) proteins were significantly downregu-
lated, while 82 (2.5 %) were significantly upregulated.
Biological significance of responses to hypoxia
To gain insight into the biological processes in which
the differentially regulated proteins are involved, the
genes coding for the proteins that were significantly dif-
ferentially expressed were analyzed in terms of GO.
The GO categories of the proteins identified as signifi-
cantly upregulated by hypoxic preconditioning comprise
several clusters of biological processes, including meta-
bolic processes, cell adhesion and ECM, developmental
processes, and responses to stimuli (Fig. 4). When looking
into the specific upregulated processes (Table 1), not sur-
prisingly the metabolic processes encompassed mostly
those necessary for anaerobic metabolism. Also, processes
related to cell adhesion and ECM were represented. Re-
garding the ECM and cell adhesion/migration, the up-
regulated proteins included prolyl 4-hydroxylases 1 and
2 (P4HA1 and 2), procollagen-lysine 2-oxoglutarate 5-
dioxygenase 1 (PLOD1), and alpha-1 chains of collagen
types 1, 3, and 7.
When looking at the GO of proteins that were
downregulated by the hypoxic preconditioning, the
processes were clustered in terms of metabolism, pro-
tein synthesis, cell cycle, and stress response (Fig. 5).
A closer look at those clusters (Table 2) revealed that
the metabolic processes most downregulated were
those related to aerobic metabolism thus complement-
ing the pattern observed for the upregulated metabolic
processes. Furthermore, several proteins involved in
multiple steps in protein synthesis were downregulated,
ranging from mRNA splicing and ribonucleoprotein
Fig. 3 Analysis of the proteome of the ASCs by mass spectrometry. a Venn diagrams showing the concurrence in identified proteins in the proteome
from the three donors (ASC 12, 21 and 23) exposed to either normoxic or hypoxic preconditioning. b Principal component analysis (PCA) of the proteome
fractions in all samples. Shown are PCA score plots of principle components 1 and 2 of the protein abundances as measured in the normoxic and hypoxic
samples from all three donors in four biological replicates. Red, ASC 12; green, ASC 21; blue, ASC 23; square, normoxic; cross, hypoxic. c Statistical analysis of
the difference between label-free samples of the proteome fraction from hypoxic preconditioned ASC 21 against the proteome fraction from normoxic
preconditioned ASC21 with a two-sided t test. The results are visualized by a scatter plot (volcano plot). The –log t test p value is plotted against the t test
difference log2 for each protein. The proteins significantly changed between the samples (p < 0.05) are in the right and left upper corners
(red). ASC adipose-derived stem cell
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complex assembly to translation elongation. Finally, the
downregulated stress response proteins were related to
detection of oxygen and DNA damage response.
Discussion
When assessing the secretome of culture cells by MS the
usual approach has been to deprive the cells of serum for
a given period of time to avoid the presence of interfering
proteins. In ASCs, however, serum deprivation has been
shown to induce a stress response that might obscure the
effect of the variable under experimental assessment, e.g.,
the oxygen tension [35, 55]. Here, as an alternative, we
assessed a commercial serum-free medium that supports
the expansion of ASCs. As high abundant proteins in
the medium supplements, such as albumin, represent
another source of interference which could dominate
the mass spectrum and limit the detection of less abundant
secreted proteins and peptides [56], two albumin-free for-
mulations compatible with MS protein analysis were evalu-
ated for the preconditioning phase.
To compare the secretome and proteome of ASCs cul-
tured under hypoxic and normoxic conditions, ASCs were
preconditioned in the MS-compatible medium for 24 h at
1 % and 20 % oxygen, after which the conditioned media
Fig. 4 Gene ontology (GO) analysis of genes upregulated by hypoxic preconditioning of ASCs. The analysis was performed in Cytoscape using
the BiNGO plug-in version 3.0.3. Presented is a reduced network showing all biological process categories that were significantly over-represented
based on the genes corresponding to the upregulated proteins identified from all three donors. The color scale indicates the level of significance
of the overrepresented GO category (adjusted p < 0.05). The size of the circles is proportional to the number of genes in each category. ECM
extracellular matrix
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and the cells were harvested. Subsequently, the condi-
tioned media were fractioned into a secretome and a pep-
tidome fraction and the cells were lysed to explore the
proteome.
After analysis of the secreted proteins in both the secre-
tome and the peptidome fraction, we identified a plethora
of proteins relevant for stem cell maintenance and tissue
regeneration. However, we were not able to detect a sig-
nificant effect of hypoxic preconditioning on the abun-
dance of these. Similarly, a recent report has shown that
hypoxic preconditioning of ASCs does not seem to largely
affect the secretion of proteins [57]. To decrease the com-
plexity of the secretome, and thereby increase the chance
of detecting low abundance proteins, we chose to fraction
the conditioned media into two fractions: the secretome
and the peptidome. However, this could be inadequate
and further fractionation could have increased the sensi-
tivity towards the low abundant proteins. It has been re-
ported that the abundances of proteins in mammalian
cells range from 1 to 107 copies per cell [58, 59]. Global
LC-MS/MS protein expression studies in cell lines have
reported 50 % coverage of all predicted proteins for
human cell lines, which is perceived as an excellent prote-
ome coverage with today’s technology [58, 59]. To
increase this in the future and enable the detection of
quantitative changes for each protein across this range
of abundances, extensive fractionation and one or more
quantitative strategies are suggested [56]. For targeting
of specific very low abundance transcription factors,
cytokines, or chemokines, a targeted MS approach will
enhance the applicability for detection and quantifica-
tion [60].
Within the proteome of ASCs a variety of proteins
were identified. Among these, a minor proportion was
found to be differently expressed in ASCs exposed to
hypoxic conditions. Among the most interesting find-
ings, hypoxic conditioning of ASCs increased the pres-
ence of proteins involved in regulation of the ECM.
Among these proteins were P4HA1 and P4HA2, which
are required for collagen synthesis and are essential to
the proper three-dimensional folding of newly synthe-
sized procollagen chains [61], and PLOD1, which cata-
lyzes the hydroxylation of lysyl residues in collagen-like
peptides on the endoplasmatic reticulum and influences
the stability of intermolecular collagen cross-links that
provide the tensile strength and mechanical stability of
collagen fibrils. Additionally, alpha-1 chains of collagen
types 1, 3, and 7 were found to be upregulated. Collagen
type 1 alpha chain 1 is a fibril-forming collagen found in
most connective tissues and is abundant in the dermis.
Table 1 Enriched biological processes based on upregulated proteins
Description Genes involved p value
Metabolism (anaerobic)
Glycolysis GPI, LDHA|TPI1, PGK1, ENO2, ALDOA, HK2, PFKP 0.0000
Gluconeogenesis GPI, TPI1, ENO2 0.0101
Fructose 1,6-bisphosphate metabolic process ALDOA, PFKP 0.0123
Glycogen biosynthetic process GYS1, GBE1 0.0285
Oxidation reduction LDHA, LOX, P4HA1, P4HA2, FTH1, CYP51A1PLOD2, PLOD1, ERO1L, LOXL2, FTL 0.0245
Protein folding LRPAP1, PFDN4, HSPBP1, PFDN6, ERO1L 0.0469
ECM and tissue development
Collagen fibril organization COL1A1, COL3A1, LOX, P4HA1 0.0010
Peptidyl-proline hydroxylation to 4-hydroxy-L-proline P4HA1, P4HA2 0.0046
Collagen biosynthetic process COL1A1, COL3A1 0.0123
Epidermis development COL1A1, COL3A1, CRABP2, COL7A1, TXNIP, PLOD1 0.0181
Cell proliferation CDV3, LRPAP1, NUMBL, CD81ZAK, FTH1, APOA1, CD276 0.0474
Cell adhesion mediated by integrin ITGA5, ICAM1 0.0255
Response to stimulus
Response to inorganic substance COL1A1, FNTA, BSG, TPM1, TXNIP, ACO1, NDRG1 0.0128
Cellular response to growth factor stimulus COL1A1, EMD 0.0333
Response to abiotic stimulus IKBIP, COL1A1, COL3A1, FECHZAK, SLC2A1, TXNIP, ERO1L 0.0333
Nucleus
Nuclear envelope organization LMNA, EMD 0.0285
Nucleocytoplasmic transport LSG1, LMNA, TXNIP, NUTF2, AGFG1 0.0285
ECM extracellular matrix
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Fig. 5 (See legend on next page.)
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Collagen type 3 alpha chain 1 is also a fibril-forming colla-
gen and is found in extensible connective tissues such as
the skin and the vascular system, frequently in association
with type I collagen. Collagen type 7 alpha chain 1 is re-
stricted to the basement zone beneath stratified squa-
mous epithelia. It functions as an anchoring fibril
between the external epithelia and the underlying
stroma, ensuring skin integrity and stability. It has been
found that intradermal administration of mesenchymal
stem cells resulted in production and deposition of col-
lagen type 7 at the dermal-epidermal junction [62].
Among these proteins, P4HA1, P4HA2, PLOD 1, and
collagen type 1 alpha chain 1 have been shown to be
under transcriptional regulation in fibroblasts by hypoxia-
inducible factor 1 (HIF-1) [61, 63]. As our preconditioning
protocol has previously been shown to stabilize HIF-1 in
these ASCs [64], the observed upregulation of the ECM-
related genes could be mediated via HIF-1. This multifa-
ceted upregulation of proteins involved in ECM produc-
tion and modulation could contribute to a restoration of
an ECM in chronic wounds that is conducive to healing,
and thus partly explains the observed wound healing ef-
fects of hypoxic ASCs.
Besides the ECM-relevant proteins, we also found
that hypoxic preconditioning significantly affected the
metabolism of the ASCs. Proteins involved in anaerobic
metabolism were found to be upregulated and proteins
involved in aerobic metabolism were found to be down-
regulated. This is well described in the literature as a
basic cellular response to hypoxic conditions, as cells
(See figure on previous page.)
Fig. 5 Gene ontology (GO) analysis of genes downregulated by hypoxic preconditioning of ASCs. The analysis was performed in Cytoscape using
the BiNGO plug-in version 3.0.3. Presented is a reduced network showing all biological process categories that were significantly over-represented
based on the genes corresponding to the downregulated proteins identified from all three donors. The color scale indicates the level of significance of
the over-represented GO category (adjusted p < 0.05). The size of the circles is proportional to the number of genes in each category
Table 2 Enriched biological processes based on downregulated proteins
Description Genes involved p value
Metabolism (aerobic)
Tricarboxylic acid cycle CS, FH, SUCLA2, MDH2, IDH3G, SUCLG2SUCLG1, ACO2, PDHB, IDH3A 0.0000
Succinyl-CoA metabolic process SUCLA2, SUCLG2, SUCLG1 0.0004
mitochondrial electron transport, NADH to ubiquinone NDUFA9, NDUFB9, NDUFA8, NDUFB8, NDUFS8, NDUFB10
NDUFS5, NDUFA10, NDUFB3, NDUFS3, DLD, NDUFV1
0.0000
Mitochondrial electron transport, ubiquinol to cytochrome c UQCRC1, UQCR10 0.0335
2-Oxoglutarate metabolic process IDH3G, DLD, IDH3A 0.0253
Malate metabolic process FH, MDH2, ME2 0.0042
Isocitrate metabolic process IDH3G, IDH3A 0.0335
Branched chain family amino acid metabolic process HIBADH, HIBCH, BCAT2 0.0298
Proline biosynthetic process PYCR1, PYCR2 0.0479
NADH metabolic process MDH2, IDH3G, IDH3A 0.0060
Aspartate transport SLC25A12, SLC25A13 0.0479
Malate-aspartate shuttle SLC25A12, SLC25A13 0.0137
Regulation of acetyl-CoA biosynthetic process from pyruvate PDP1, PDHB, DLD 0.0128
Oxaloacetate metabolic process CS, MDH2, PCK2 0.0106
Protein targeting to mitochondrion TOMM40, TOMM34, TIMM44, TOMM22 0.0198
Gene expression
Nuclear mRNA splicing, via spliceosome SF3B4, PRPF4, SF3A2, SNRPD1, DHX38GEMIN5, USP39, WDR77, LSM2 0.0001
Translational elongation GFM1, RPL21, RPL22, RPL13, RPL27, EEF2, TUFM 0.0099
DNA-dependent DNA replication initiation MCM7, MCM3, MCM6 0.0253
tRNA modification QTRT1, SSB, NSUN2 0.0335
Ribonucleoprotein complex assembly SF3A2, SNRPD1, CIRBP, GEMIN5, USP39, WDR77 0.0147
Response to stress
Detection of oxygen SOD2, ENG 0.0335
DNA damage response, detection of DNA damage MRPS9, PARP1, MRPS35 0.0017
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during hypoxia rapidly enter a state of metabolic crisis
which requires a fundamental shift in cellular metabolic
strategy to facilitate the entering of an adaptive state
which supports tissue survival [65]. This is very effect-
ive in ASCs, and hypoxic preconditioning has been
shown to enhance the survival and regenerative poten-
tial of ASCs in vivo [14, 66–71].
Stress-related proteins were also downregulated by
hypoxic conditioning. Among these were the poly(ADP-
ribose) polymerase 1, which is involved in the regulation
of various important cellular processes such as differen-
tiation and proliferation. Others have found that 1 % O2
maintains stem cells in an undifferentiated state [72] and
we have earlier shown that hypoxia at 1 % O2 decreases
the proliferation of ASCs [16]. Poly(ADP-ribose) poly-
merase 1 could be involved in this.
Furthermore, proteins involved in protein translation
were also found to be downregulated. Among these were
proteins involved in mRNA splicing, ribonucleoprotein
complex assembly and translation elongation as splicing
factors binding to pre-mRNA, ribosomal proteins and
the essential translation elongation factor 2 promoting
the GTP-dependent translocation of the nascent pro-
tein chain from the A-site to the P-site of the ribo-
somes. It has previously been shown that moderate
hypoxia of 1–0.1 % O2 affects gene expression, tran-
scription, mRNA stability, protein synthesis and post-
translational modifications [73]. The downregulation of
the broad range of proteins related to translation that
we observed in this study could therefore provide an
explanation for the general decrease in protein synthe-
sis by hypoxia.
Based on our findings and analysis, the explanation of
the regenerative effect of ASCs was not to be found within
the proteome. Despite the ECM-relevant proteins and a
few others, the approach did not reveal differences in
secretome abundance of other low abundant wound heal-
ing relevant factors. The majority of the proteins identified
by MS were 1.11 ± 2.98-fold regulated and only a very
small fraction of these was regulated by hypoxia. Earlier,
we have shown hypoxic preconditioning to increase the
level of VEGF two-fold as measured by ELISA which was
found to be statistically significant compared to the
normoxic levels of VEGF [64]. The analytical approach
applied in this study allows for the discovery of un-
known proteins as the data was compared to complete
databases of all known proteins and their isoforms;
however, the molecular size of multiple growth factors
limits the detection by discovery proteomics. The de-
tection of very low abundance cytokines and chemo-
kines could be improved by targeted MS approaches
such as MRM or PRM [60]. By combining our novel
growth and fractionation approach, novel wound heal-
ing candidates could be discovered.
Conclusions
In this study, we described a new serum-free culturing
methodology to obtain conditioned medium from ASCs
for MS analysis. Optimal cell growth, viability, and morph-
ology were obtained using StemPro® SFM XenoFree basal
medium containing the regular supplements during the
expansion phase and, to avoid serum starvation and elim-
inate albumin interference, Essential 8™ supplements
during the conditioning phase. While analysis of the
secretome did not reveal any significant hypoxia-induced
up- or downregulation of proteins, a relatively small frac-
tion of the proteome was significantly affected by hypoxia.
The main effects comprised ECM-relevant proteins ensur-
ing tensile strength, three-dimensional folding, and mech-
anical stability of collagen fibrils in the dermis ensuring
skin integrity and stability. Additionally, we found a switch
in metabolism-relevant proteins indicating a change from
aerobic to anaerobic metabolism. Although we could not
find evidence supporting an enhanced secretion of pro-
regenerative proteins by ASCs under hypoxia, this study
provides a basis for further studies using proteomic tech-
niques for the characterization of the ASC secretome.
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